Some people are paying more than $10,000 a year for Ozempic and Mounjaro. Source link
Drug regulators said they have received several reports of suspected suicidal and self-injurious behavior in patients taking the drugs. Source…
Ozempic is under review by European drug-safety regulators after they received reports of suicidal thoughts linked to the popular weight-loss…
MarketsHeard on the StreetStrong sales of obesity-diabetes drugs known as GLP-1s could affect insurance companies’ financial results Source link
Provincial health officials urged doctors and pharmacists to make sure people are taking the drug to treat diabetes, not lose…